OverviewSuggest Edit

Pixium Vision is developing retinal implant systems for patients who have lost their sight, with the intention of improving their vision and enabling them to lead more independent lives. The Company intends to harness the rapid advances being made in neural processing, micro-electronics and computing to develop retinal implant systems that for blind people could ultimately provide vision approaching that of a normal healthy Pixium's first device, IRIS1 (Intelligent Retinal Implantable System), uses an epi-retinal implant (on the retinal surface) and is currently in clinical trials with the goal of obtaining CE Mark. A second generation system (IRIS2) based on the same format, but offering better visual acuity and featuring several breakthrough technologies, is also under development. In addition, Pixium is developing a sub-retinal implant system (IRIS3), based on further technological breakthroughs, which has the potential to improve vision significantly compared to IRIS1 and IRIS2. Pixium was created in Paris, France in November 2011 as a spin-out of the Vision Institute and Université Pierre et Marie Curie, and based on collaborative work involving several leading academic teams across Europe. Pixium is backed by a syndicate of blue-chip European venture capital firms including Sofinnova Partners, Omnes Capital, Abingworth, Global Life Sciences Ventures, Seventure and Polytechnos.
TypePublic
Founded2011
HQParis, FR
Websitepixium-vision.com

Latest Updates

Employees (est.) (Feb 2020)30
Share Price (Oct 2017)€3.1
Cybersecurity ratingAMore

Key People/Management at Pixium Vision

Guillaume Buc

Guillaume Buc

CTO
Karine Chevrie

Karine Chevrie

Regulatory Affairs and Quality Director
Ralf Hornig

Ralf Hornig

Director of Clinical Affairs
Lloyd Diamond

Lloyd Diamond

CEO
Didier Laurens

Didier Laurens

Financial Director
Show more

Pixium Vision Office Locations

Pixium Vision has an office in Paris
Paris, FR (HQ)
74 Rue du Faubourg Saint-Antoine
Show all (1)

Pixium Vision Financials and Metrics

Pixium Vision Revenue

Market capitalization (31-Oct-2017)

40.2m

Closing stock price (31-Oct-2017)

3.1
Pixium Vision's current market capitalization is €40.2 m.
Show all financial metrics

Pixium Vision Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

Pixium Vision Online and Social Media Presence

Embed Graph

Pixium Vision News and Updates

Pixium Vision and Second Sight Medical Products announce business combination, creating a global leader in the sight restoration market

Pixium Vision and Second Sight Medical Products announce business combination, creating a global leader in the sight restoration market

Pixium Vision receives French regulatory authority (ANSM) approval to initiate European PRIMAvera pivotal study of Prima System

Pixium Vision receives French regulatory authority (ANSM) approval to initiate European PRIMAvera pivotal study of Prima System

Pixium Vision announces its cash position at 30 September 2020

                

Pixium Vision Hosting Key Opinion Leader Webinar on the Prima System for Atrophic Dry Age-related Macular Degeneration (dry-AMD)

Pixium Vision Hosting Key Opinion Leader Webinar on the Prima System for Atrophic Dry Age-related Macular Degeneration (dry-AMD)

Pixium Vision notified of threshold crossing following passive dilution

Pixium Vision notified of threshold crossing following passive dilution
Show more

Pixium Vision Blogs

H2 2020 update on Pixium Vision’s liquidity agreement with Gilbert Dupont

Download the PDF The post H2 2020 update on Pixium Vision’s liquidity agreement with Gilbert Dupont appeared first on Pixium Vision.

Information on total number of voting rights and shares composing the share capital as at December 31st, 2020

Download PDF The post Information on total number of voting rights and shares composing the share capital as at December 31st, 2020 appeared first on Pixium Vision.

OCA follow-up – Situation on December 1st, 2020

Download PDF The post OCA follow-up – Situation on December 1st, 2020 appeared first on Pixium Vision.

Information on total number of voting rights and shares composing the share capital as at November 31st, 2020

Download the PDF The post Information on total number of voting rights and shares composing the share capital as at November 31st, 2020 appeared first on Pixium Vision.

Edison Research raises valuation to €134.0m base on approval of PRIMAvera study

Download PDF The post Edison Research raises valuation to €134.0m base on approval of PRIMAvera study appeared first on Pixium Vision.

Shareholder structure of Pixium Vision following the capital increase with pre-emptive subscription rights of €7.3 million

Download PDF The post Shareholder structure of Pixium Vision following the capital increase with pre-emptive subscription rights of €7.3 million appeared first on Pixium Vision.
Show more

Pixium Vision Frequently Asked Questions

  • When was Pixium Vision founded?

    Pixium Vision was founded in 2011.

  • Who are Pixium Vision key executives?

    Pixium Vision's key executives are Guillaume Buc, Karine Chevrie and Ralf Hornig.

  • How many employees does Pixium Vision have?

    Pixium Vision has 30 employees.

  • Who are Pixium Vision competitors?

    Competitors of Pixium Vision include Karl Storz, EarLens and Affluent Medical.

  • Where is Pixium Vision headquarters?

    Pixium Vision headquarters is located at 74 Rue du Faubourg Saint-Antoine, Paris.

  • Where are Pixium Vision offices?

    Pixium Vision has an office in Paris.

  • How many offices does Pixium Vision have?

    Pixium Vision has 1 office.